UnitedHealth Group Inc (UNH) Director Richard T. Burke Sells 10,400 Shares
UnitedHealth Group Inc (NYSE:UNH) Director Richard T. Burke sold 10,400 shares of the business’s stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $229.87, for a total value of $2,390,648.00. Following the completion of the transaction, the director now owns 1,781,657 shares in the company, valued at approximately $409,549,494.59. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
UnitedHealth Group Inc (NYSE UNH) opened at $225.19 on Monday. The company has a market capitalization of $217,910.00, a P/E ratio of 23.70, a PEG ratio of 1.31 and a beta of 0.74. UnitedHealth Group Inc has a fifty-two week low of $162.74 and a fifty-two week high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business’s revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the company earned $2.11 earnings per share. sell-side analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.
UNH has been the topic of several research reports. Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 27th. Evercore ISI restated an “outperform” rating and set a $255.00 price objective (up previously from $235.00) on shares of UnitedHealth Group in a research note on Friday, January 12th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective on the stock in a research note on Saturday, January 20th. Wells Fargo & Co restated an “outperform” rating and set a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Finally, ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Two analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $243.22.
A number of hedge funds have recently modified their holdings of UNH. Beach Investment Management LLC. bought a new position in UnitedHealth Group in the 2nd quarter worth approximately $556,000. Svenska Handelsbanken AB publ boosted its stake in UnitedHealth Group by 112.1% during the 2nd quarter. Svenska Handelsbanken AB publ now owns 12,300 shares of the healthcare conglomerate’s stock valued at $2,281,000 after purchasing an additional 6,500 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in UnitedHealth Group by 10.1% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 53,549 shares of the healthcare conglomerate’s stock valued at $9,929,000 after purchasing an additional 4,925 shares in the last quarter. Brighton Jones LLC bought a new position in UnitedHealth Group during the 2nd quarter valued at $545,000. Finally, Girard Partners LTD. boosted its stake in UnitedHealth Group by 6.9% during the 2nd quarter. Girard Partners LTD. now owns 34,161 shares of the healthcare conglomerate’s stock valued at $6,334,000 after purchasing an additional 2,199 shares in the last quarter. 85.65% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Inc (UNH) Director Richard T. Burke Sells 10,400 Shares” was posted by Watch List News and is the property of of Watch List News. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.watchlistnews.com/unitedhealth-group-inc-unh-director-richard-t-burke-sells-10400-shares/1908353.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.